These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. CDC recommends only 2 HPV doses for younger adolescents. Printz C Cancer; 2017 May; 123(9):1485. PubMed ID: 28430362 [No Abstract] [Full Text] [Related]
26. Vaccines for the prevention of human papillomavirus infections. Speck LM; Tyring SK Skin Therapy Lett; 2006; 11(6):1-3. PubMed ID: 16912836 [TBL] [Abstract][Full Text] [Related]
27. Leadership in Immunization: the relevance to Japan of the U.S.A. experience of the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP). Kamiya H; Okabe N Vaccine; 2009 Mar; 27(11):1724-8. PubMed ID: 19186205 [TBL] [Abstract][Full Text] [Related]
28. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus. Broomall EM; Reynolds SM; Jacobson RM Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463 [TBL] [Abstract][Full Text] [Related]
29. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States. Grant LA; Dunne EF; Chesson H; Markowitz LE Vaccine; 2011 Mar; 29(13):2365-70. PubMed ID: 21277406 [TBL] [Abstract][Full Text] [Related]
30. StatBite: Prevalence of HPV in a cohort of U.S. men. J Natl Cancer Inst; 2009 Feb; 101(4):223. PubMed ID: 19211451 [No Abstract] [Full Text] [Related]
31. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer. Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739 [TBL] [Abstract][Full Text] [Related]
32. Introducing human papillomavirus (HPV) vaccination - a challenge for European Vaccine Advisory Committees and Public Health Services. Pfleiderer M Euro Surveill; 2008 Aug; 13(33):. PubMed ID: 18761895 [No Abstract] [Full Text] [Related]
33. Post-licensure monitoring of HPV vaccine in the United States. Markowitz LE; Hariri S; Unger ER; Saraiya M; Datta SD; Dunne EF Vaccine; 2010 Jul; 28(30):4731-7. PubMed ID: 20188681 [TBL] [Abstract][Full Text] [Related]
34. Cervarix--a second HPV vaccine. Med Lett Drugs Ther; 2010 May; 52(1338):37-8. PubMed ID: 20467355 [No Abstract] [Full Text] [Related]
35. Questions over human papillomavirus vaccine in the US and Australia. Tanne JH BMJ; 2007 Jun; 334(7605):1182-3. PubMed ID: 17556447 [No Abstract] [Full Text] [Related]
36. Acceptability of human papillomavirus vaccine for males: a review of the literature. Liddon N; Hood J; Wynn BA; Markowitz LE J Adolesc Health; 2010 Feb; 46(2):113-23. PubMed ID: 20113917 [TBL] [Abstract][Full Text] [Related]
37. Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. Brown DS; Johnson FR; Poulos C; Messonnier ML Vaccine; 2010 Feb; 28(7):1702-8. PubMed ID: 20044060 [TBL] [Abstract][Full Text] [Related]
38. Age considerations when vaccinating against HPV. Wright TC; Huh WK; Monk BJ; Smith JS; Ault K; Herzog TJ Gynecol Oncol; 2008 May; 109(2 Suppl):S40-7. PubMed ID: 18482558 [TBL] [Abstract][Full Text] [Related]
39. Factors associated with parental intentions for male human papillomavirus vaccination: results of a national survey. Dempsey AF; Butchart A; Singer D; Clark S; Davis M Sex Transm Dis; 2011 Aug; 38(8):769-76. PubMed ID: 21336230 [TBL] [Abstract][Full Text] [Related]
40. Who should get the HPV vaccine? Pichichero ME J Fam Pract; 2007 Mar; 56(3):197-202. PubMed ID: 17343808 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]